$NVIV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INVIVO THERAPEUTICS HOLDINGS CORP..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INVIVO THERAPEUTICS HOLDINGS CORP.. Get notifications about new insider transactions in INVIVO THERAPEUTICS HOLDINGS CORP. for free.
Page: < prev 1 2 3 4 5 5 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 05 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.44 | 12,500 | 30,500 | 9,748,920 | 9.8 M to 9.7 M (-0.13 %) |
Mar 05 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.52 | 12,500 | 31,500 | 9,761,420 | 9.8 M to 9.8 M (-0.13 %) |
Mar 05 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.52 | 12,500 | 31,500 | 9,773,920 | 9.8 M to 9.8 M (-0.13 %) |
Feb 24 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.23 | 12,500 | 27,875 | 9,836,420 | 9.8 M to 9.8 M (-0.13 %) |
Feb 24 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.23 | 12,500 | 27,875 | 9,848,920 | 9.9 M to 9.8 M (-0.13 %) |
Feb 26 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.31 | 12,500 | 28,875 | 9,798,920 | 9.8 M to 9.8 M (-0.13 %) |
Feb 26 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.28 | 12,500 | 28,500 | 9,811,420 | 9.8 M to 9.8 M (-0.13 %) |
Feb 26 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.24 | 12,500 | 28,000 | 9,823,920 | 9.8 M to 9.8 M (-0.13 %) |
Feb 19 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.23 | 12,500 | 27,875 | 9,861,420 | 9.9 M to 9.9 M (-0.13 %) |
Feb 19 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.26 | 12,500 | 28,250 | 9,873,920 | 9.9 M to 9.9 M (-0.13 %) |
Feb 14 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.24 | 12,500 | 28,000 | 9,886,420 | 9.9 M to 9.9 M (-0.13 %) |
Feb 14 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.23 | 12,500 | 27,875 | 9,898,920 | 9.9 M to 9.9 M (-0.13 %) |
Feb 12 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.24 | 12,500 | 28,000 | 9,898,920 | 9.9 M to 9.9 M (-0.13 %) |
Feb 12 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.25 | 12,500 | 28,125 | 9,911,420 | 9.9 M to 9.9 M (-0.13 %) |
Feb 12 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.25 | 12,500 | 28,125 | 9,923,920 | 9.9 M to 9.9 M (-0.13 %) |
Feb 07 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.23 | 12,500 | 27,875 | 9,936,420 | 9.9 M to 9.9 M (-0.13 %) |
Feb 07 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.23 | 12,500 | 27,875 | 9,948,920 | 10 M to 9.9 M (-0.13 %) |
Feb 06 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.21 | 12,500 | 27,625 | 9,961,428 | 10 M to 10 M (-0.13 %) |
Feb 06 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.24 | 12,500 | 28,000 | 9,973,920 | 10 M to 10 M (-0.13 %) |
Feb 06 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.19 | 12,500 | 27,375 | 9,986,420 | 10 M to 10 M (-0.13 %) |
Jan 31 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.16 | 12,500 | 27,000 | 9,998,920 | 10 M to 10 M (-0.12 %) |
Jan 31 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.17 | 12,500 | 27,125 | 10,011,420 | 10 M to 10 M (-0.12 %) |
Jan 29 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.19 | 12,500 | 27,375 | 10,023,920 | 10 M to 10 M (-0.12 %) |
Jan 29 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.21 | 12,500 | 27,625 | 10,036,420 | 10 M to 10 M (-0.12 %) |
Jan 29 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.25 | 12,500 | 28,125 | 100,048,920 | 100.1 M to 100 M (-0.01 %) |
Jan 27 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.26 | 12,500 | 28,250 | 10,051,920 | 10.1 M to 10.1 M (-0.12 %) |
Jan 27 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.23 | 12,500 | 27,875 | 10,064,420 | 10.1 M to 10.1 M (-0.12 %) |
Jan 22 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.37 | 12,500 | 29,625 | 10,076,920 | 10.1 M to 10.1 M (-0.12 %) |
Jan 22 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.38 | 12,500 | 29,750 | 10,089,920 | 10.1 M to 10.1 M (-0.12 %) |
Jan 22 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.34 | 12,500 | 29,250 | 10,101,920 | 10.1 M to 10.1 M (-0.12 %) |
Jan 15 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.25 | 12,500 | 28,125 | 10,114,420 | 10.1 M to 10.1 M (-0.12 %) |
Jan 15 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.21 | 12,500 | 27,625 | 10,126,920 | 10.1 M to 10.1 M (-0.12 %) |
Jan 15 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.21 | 12,500 | 27,625 | 10,139,420 | 10.2 M to 10.1 M (-0.12 %) |
Jan 13 2014 | NVIV | INVIVO THERAPEUTIC ... | ASTRUE MICHAEL J | INTERIM CEO | Grant | A | 0.00 | 108,848 | 0 | 108,848 | 0 to 108.8 K |
Jan 10 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.28 | 12,000 | 27,360 | 10,151,920 | 10.2 M to 10.2 M (-0.12 %) |
Jan 10 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.42 | 12,000 | 29,040 | 10,163,920 | 10.2 M to 10.2 M (-0.12 %) |
Jan 10 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.49 | 12,000 | 29,880 | 10,175,920 | 10.2 M to 10.2 M (-0.12 %) |
Jan 10 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.43 | 12,000 | 29,160 | 10,187,290 | 10.2 M to 10.2 M (-0.12 %) |
Jan 09 2014 | NVIV | INVIVO THERAPEUTIC ... | PERRIN MARK D | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 2.35 | 2,000,000 | 4,700,000 | 2,000,000 | |
Jan 07 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.42 | 12,000 | 29,040 | 10,199,920 | 10.2 M to 10.2 M (-0.12 %) |
Jan 07 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.19 | 12,000 | 26,280 | 10,211,920 | 10.2 M to 10.2 M (-0.12 %) |
Jan 07 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.23 | 12,000 | 26,760 | 10,223,920 | 10.2 M to 10.2 M (-0.12 %) |
Jan 02 2014 | NVIV | INVIVO THERAPEUTIC ... | PERRY GREGORY D | Interim CFO | Grant | A | 0.00 | 22,374 | 0 | 22,374 | 0 to 22.4 K |
Jan 02 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.16 | 12,000 | 25,920 | 10,235,920 | 10.2 M to 10.2 M (-0.12 %) |
Jan 02 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.26 | 12,000 | 27,120 | 10,247,920 | 10.3 M to 10.2 M (-0.12 %) |
Jan 02 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.34 | 12,000 | 28,080 | 10,259,920 | 10.3 M to 10.3 M (-0.12 %) |
Dec 26 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.06 | 12,000 | 24,720 | 10,271,920 | 10.3 M to 10.3 M (-0.12 %) |
Dec 26 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.96 | 12,000 | 23,520 | 10,283,920 | 10.3 M to 10.3 M (-0.12 %) |
Dec 26 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.94 | 12,000 | 23,280 | 10,295,920 | 10.3 M to 10.3 M (-0.12 %) |
Dec 20 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.98 | 12,000 | 23,760 | 10,307,920 | 10.3 M to 10.3 M (-0.12 %) |
Dec 20 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.93 | 12,000 | 23,160 | 10,319,920 | 10.3 M to 10.3 M (-0.12 %) |
Dec 20 2013 | NVIV | INVIVO THERAPEUTIC ... | HESS BRIAN | Chief Technology Of ... | Option Exercise | A | 1.95 | 75,000 | 146,250 | 75,000 | |
Dec 13 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.74 | 12,000 | 20,880 | 10,367,920 | 10.4 M to 10.4 M (-0.12 %) |
Dec 13 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.86 | 12,000 | 22,320 | 10,379,920 | 10.4 M to 10.4 M (-0.12 %) |
Dec 19 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.96 | 12,000 | 23,520 | 10,331,920 | 10.3 M to 10.3 M (-0.12 %) |
Dec 19 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.90 | 12,000 | 22,800 | 10,343,920 | 10.4 M to 10.3 M (-0.12 %) |
Dec 19 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.83 | 12,000 | 21,960 | 10,355,920 | 10.4 M to 10.4 M (-0.12 %) |
Dec 12 2013 | NVIV | INVIVO THERAPEUTIC ... | DiPietro Kenneth | Director | Option Exercise | A | 1.78 | 50,000 | 89,000 | 50,000 | |
Dec 12 2013 | NVIV | INVIVO THERAPEUTIC ... | ROBERTS RICHARD JOHN | Director | Option Exercise | A | 1.78 | 50,000 | 89,000 | 50,000 | |
Dec 12 2013 | NVIV | INVIVO THERAPEUTIC ... | MCCARTHY JOHN A JR | Director | Option Exercise | A | 1.78 | 50,000 | 89,000 | 50,000 | |
Dec 11 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.98 | 12,000 | 23,760 | 10,391,920 | 10.4 M to 10.4 M (-0.12 %) |
Dec 11 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.71 | 12,000 | 20,520 | 10,403,920 | 10.4 M to 10.4 M (-0.12 %) |
Dec 11 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.56 | 12,000 | 18,720 | 10,415,920 | 10.4 M to 10.4 M (-0.12 %) |
Dec 06 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.52 | 12,000 | 18,240 | 10,427,920 | 10.4 M to 10.4 M (-0.11 %) |
Dec 06 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.66 | 12,000 | 19,920 | 10,439,920 | 10.5 M to 10.4 M (-0.11 %) |
Dec 04 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.76 | 12,000 | 21,120 | 10,451,920 | 10.5 M to 10.5 M (-0.11 %) |
Dec 04 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.95 | 12,000 | 23,400 | 10,463,920 | 10.5 M to 10.5 M (-0.11 %) |
Dec 04 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.00 | 12,000 | 24,000 | 10,475,920 | 10.5 M to 10.5 M (-0.11 %) |
Nov 29 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.97 | 12,000 | 23,640 | 10,487,920 | 10.5 M to 10.5 M (-0.11 %) |
Nov 29 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.03 | 12,000 | 24,360 | 10,499,920 | 10.5 M to 10.5 M (-0.11 %) |
Nov 29 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.00 | 12,000 | 24,000 | 10,511,920 | 10.5 M to 10.5 M (-0.11 %) |
Nov 29 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.00 | 12,000 | 24,000 | 10,523,920 | 10.5 M to 10.5 M (-0.11 %) |
Nov 22 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.99 | 12,000 | 23,880 | 10,535,920 | 10.5 M to 10.5 M (-0.11 %) |
Nov 22 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.85 | 12,000 | 22,200 | 10,547,920 | 10.6 M to 10.5 M (-0.11 %) |
Nov 15 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.47 | 12,000 | 17,640 | 10,595,920 | 10.6 M to 10.6 M (-0.11 %) |
Nov 15 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.14 | 12,000 | 13,680 | 10,607,920 | 10.6 M to 10.6 M (-0.11 %) |
Nov 20 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.88 | 12,000 | 22,560 | 10,559,920 | 10.6 M to 10.6 M (-0.11 %) |
Nov 20 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.91 | 12,000 | 22,920 | 10,571,920 | 10.6 M to 10.6 M (-0.11 %) |
Nov 20 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.07 | 12,000 | 24,840 | 10,583,920 | 10.6 M to 10.6 M (-0.11 %) |
Nov 08 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.11 | 12,000 | 13,320 | 10,643,920 | 10.7 M to 10.6 M (-0.11 %) |
Nov 08 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.11 | 12,000 | 13,320 | 10,655,920 | 10.7 M to 10.7 M (-0.11 %) |
Nov 13 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.15 | 12,000 | 13,800 | 10,607,920 | 10.6 M to 10.6 M (-0.11 %) |
Nov 13 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.15 | 12,000 | 13,800 | 10,619,920 | 10.6 M to 10.6 M (-0.11 %) |
Nov 13 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.13 | 12,000 | 13,560 | 10,631,920 | 10.6 M to 10.6 M (-0.11 %) |
Nov 01 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.15 | 12,000 | 13,800 | 10,691,920 | 10.7 M to 10.7 M (-0.11 %) |
Nov 01 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.17 | 12,000 | 14,040 | 10,703,920 | 10.7 M to 10.7 M (-0.11 %) |
Nov 06 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.14 | 12,000 | 13,680 | 10,655,920 | 10.7 M to 10.7 M (-0.11 %) |
Nov 06 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.17 | 12,000 | 14,040 | 10,667,920 | 10.7 M to 10.7 M (-0.11 %) |
Nov 06 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.17 | 12,000 | 14,040 | 10,679,920 | 10.7 M to 10.7 M (-0.11 %) |
Oct 23 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | P | 1.38 | 12,000 | 16,560 | 10,763,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 23 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.39 | 12,000 | 16,680 | 10,775,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 23 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.41 | 12,000 | 16,920 | 10,787,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 31 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.18 | 12,000 | 14,160 | 10,715,920 | 10.7 M to 10.7 M (-0.11 %) |
Oct 31 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.23 | 12,000 | 14,760 | 10,727,920 | 10.7 M to 10.7 M (-0.11 %) |
Oct 31 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.29 | 12,000 | 15,480 | 10,739,920 | 10.8 M to 10.7 M (-0.11 %) |
Oct 21 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.45 | 12,000 | 17,400 | 10,799,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 21 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.45 | 12,000 | 17,400 | 10,811,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 25 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.33 | 12,000 | 15,960 | 10,751,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 25 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.37 | 12,000 | 16,440 | 10,763,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 16 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.49 | 12,000 | 17,880 | 10,787,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 16 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.49 | 12,000 | 17,880 | 10,799,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 16 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.49 | 12,000 | 17,880 | 10,811,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 15 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.50 | 12,000 | 18,000 | 10,823,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 15 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.52 | 12,000 | 18,240 | 10,835,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 09 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.49 | 12,000 | 17,880 | 10,847,920 | 10.9 M to 10.8 M (-0.11 %) |
Oct 09 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.40 | 12,000 | 16,800 | 10,859,920 | 10.9 M to 10.9 M (-0.11 %) |
Oct 09 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.34 | 12,000 | 16,080 | 10,871,920 | 10.9 M to 10.9 M (-0.11 %) |
Oct 07 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.39 | 12,000 | 16,680 | 10,883,920 | 10.9 M to 10.9 M (-0.11 %) |
Oct 07 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.42 | 12,000 | 17,040 | 10,895,920 | 10.9 M to 10.9 M (-0.11 %) |
Oct 02 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.42 | 12,000 | 17,040 | 10,907,920 | 10.9 M to 10.9 M (-0.11 %) |
Oct 02 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.41 | 12,000 | 16,920 | 10,919,920 | 10.9 M to 10.9 M (-0.11 %) |
Oct 02 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.46 | 12,000 | 17,520 | 10,931,920 | 10.9 M to 10.9 M (-0.11 %) |
Sep 27 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.54 | 12,000 | 18,480 | 10,943,920 | 11 M to 10.9 M (-0.11 %) |
Sep 27 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.62 | 12,000 | 19,440 | 10,955,920 | 11 M to 11 M (-0.11 %) |
Sep 27 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.61 | 12,000 | 19,320 | 10,967,920 | 11 M to 11 M (-0.11 %) |
Sep 27 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.47 | 12,000 | 17,640 | 10,979,920 | 11 M to 11 M (-0.11 %) |
Sep 27 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Gift | G | 0.00 | 400,000 | 0 | 10,991,920 | 11.4 M to 11 M (-3.51 %) |
Sep 27 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.40 | 12,000 | 16,800 | 11,391,920 | 11.4 M to 11.4 M (-0.11 %) |
Sep 20 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.37 | 12,000 | 16,440 | 11,403,920 | 11.4 M to 11.4 M (-0.11 %) |
Sep 20 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.37 | 12,000 | 16,440 | 11,415,920 | 11.4 M to 11.4 M (-0.11 %) |
Sep 18 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.37 | 12,000 | 16,440 | 11,427,920 | 11.4 M to 11.4 M (-0.10 %) |
Sep 18 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.50 | 12,000 | 18,000 | 11,439,920 | 11.5 M to 11.4 M (-0.10 %) |
Sep 18 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.43 | 12,000 | 17,160 | 11,451,920 | 11.5 M to 11.5 M (-0.10 %) |
Sep 13 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.50 | 12,000 | 18,000 | 11,463,920 | 11.5 M to 11.5 M (-0.10 %) |
Sep 13 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.49 | 12,000 | 17,880 | 11,475,920 | 11.5 M to 11.5 M (-0.10 %) |
Sep 11 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.53 | 12,000 | 18,360 | 11,487,920 | 11.5 M to 11.5 M (-0.10 %) |
Sep 11 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.91 | 12,000 | 22,920 | 11,499,920 | 11.5 M to 11.5 M (-0.10 %) |
Sep 06 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.62 | 12,000 | 19,440 | 11,511,920 | 11.5 M to 11.5 M (-0.10 %) |
Sep 06 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.60 | 12,000 | 19,200 | 11,523,920 | 11.5 M to 11.5 M (-0.10 %) |
Sep 04 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.53 | 12,000 | 18,360 | 11,535,920 | 11.5 M to 11.5 M (-0.10 %) |
Sep 04 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Gift | G | 0.00 | 1,000,000 | 0 | 11,547,920 | 12.5 M to 11.5 M (-7.97 %) |
Sep 04 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.18 | 12,000 | 14,160 | 12,547,920 | 12.6 M to 12.5 M (-0.10 %) |
Sep 04 2013 | NVIV | INVIVO THERAPEUTIC ... | Moran Sean F. | Acting Chief Financ ... | Buy | P | 1.02 | 20,000 | 20,400 | 60,000 | 40 K to 60 K (+50.00 %) |
Sep 03 2013 | NVIV | INVIVO THERAPEUTIC ... | Moran Sean F. | Acting Chief Financ ... | Buy | S | 1.47 | 12,000 | 17,640 | 40,000 | 28 K to 40 K (+42.86 %) |
Sep 03 2013 | NVIV | INVIVO THERAPEUTIC ... | Moran Sean F. | Acting Chief Financ ... | Buy | S | 1.23 | 28,000 | 34,440 | 28,000 | 0 to 28 K |
Aug 30 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.40 | 3,300 | 4,620 | 12,559,920 | 12.6 M to 12.6 M (-0.03 %) |
Aug 30 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.63 | 5,900 | 9,617 | 12,563,220 | 12.6 M to 12.6 M (-0.05 %) |
Aug 28 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.92 | 600 | 1,152 | 12,569,120 | 12.6 M to 12.6 M (0.00 %) |
Aug 28 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 3.31 | 12,000 | 39,720 | 12,569,720 | 12.6 M to 12.6 M (-0.10 %) |
Aug 23 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 3.92 | 9,300 | 36,456 | 12,581,720 | 12.6 M to 12.6 M (-0.07 %) |
Aug 23 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 4.19 | 12,000 | 50,280 | 12,591,020 | 12.6 M to 12.6 M (-0.10 %) |
Aug 21 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 4.19 | 12,000 | 50,280 | 12,603,020 | 12.6 M to 12.6 M (-0.10 %) |
Aug 21 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 4.10 | 12,000 | 49,200 | 12,615,020 | 12.6 M to 12.6 M (-0.10 %) |
Aug 21 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 4.08 | 12,000 | 48,960 | 12,627,020 | 12.6 M to 12.6 M (-0.09 %) |
Aug 16 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 4.17 | 12,000 | 50,040 | 12,639,020 | 12.7 M to 12.6 M (-0.09 %) |
Aug 16 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 4.30 | 12,000 | 51,600 | 12,651,020 | 12.7 M to 12.7 M (-0.09 %) |
Aug 14 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 4.27 | 12,000 | 51,240 | 12,663,020 | 12.7 M to 12.7 M (-0.09 %) |
Aug 14 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 4.34 | 12,000 | 52,080 | 12,675,020 | 12.7 M to 12.7 M (-0.09 %) |
Aug 14 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 4.41 | 12,000 | 52,920 | 12,687,020 | 12.7 M to 12.7 M (-0.09 %) |
Aug 09 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 4.31 | 12,000 | 51,720 | 12,699,020 | 12.7 M to 12.7 M (-0.09 %) |